Melan‐A positive dermal cells in malignant melanoma in situ

The presence of Melan‐A positive dermal cells in excisions for melanoma in situ represents a frequent conundrum for pathologists. These cells may represent superficially invasive melanoma, benign, incidental, dermal nevi or non‐specific staining of dermal melanophages. Occasionally, rare, Melan‐A positive dermal cells are present which do not clearly correspond to the above three categories. Our objective was to further characterize these Melan‐A positive dermal cells. To do this, immunoperoxidase staining for Melan‐A and SOX‐10 was performed on 188‐cutaneous excisions, including examples of melanoma in situ, atypical junctional melanocytic hyperplasia and non‐melanocytic tumors. These were evaluated for the presence of Melan‐A and SOX‐10 positive dermal cells. Dermal cells, positive for both markers, were identified in 17% of the excisions. The cells were present in 10% of cases from the melanocytic group and 31% of the cases from the non‐melanocytic group. These cells did not exhibit cytologic atypia and resembled neither the co‐existing neoplasm nor melanophages. We conclude that positivity of these rare Melan‐A positive cells for SOX‐10 argues that they represent true melanocytes and not non‐specific staining. The absence of cytologic atypia in these cells and their presence in excisions of non‐melanocytic neoplasms argues that they are benign, reactive, dermal melanocytes.

[1]  J. Grichnik,et al.  Conceptual approach to early melanoma detection: models, tools, issues and challenges. , 2015, Melanoma management.

[2]  D. Munoz,et al.  Sox10 is Superior to S100 in the Diagnosis of Meningioma , 2015, Applied immunohistochemistry & molecular morphology : AIMM.

[3]  A. Robson,et al.  Evaluation of the Role of Routine Melan-A Immunohistochemistry for Exclusion of Microinvasion in 120 Cases of Lentigo Maligna , 2014, The American Journal of dermatopathology.

[4]  I. Yeh,et al.  SOX‐10 expression in cutaneous myoepitheliomas and mixed tumors , 2014, Journal of cutaneous pathology.

[5]  A. Folpe,et al.  Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma , 2014, Modern Pathology.

[6]  J. Taube,et al.  Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses. , 2012, Journal of the American Academy of Dermatology.

[7]  Emi K Nishimura,et al.  Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation , 2011, Pigment cell & melanoma research.

[8]  J. Karamchandani,et al.  SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar , 2010, Journal of cutaneous pathology.

[9]  M. Flaig,et al.  Pitfalls of Melan‐A staining , 2009, Journal of cutaneous pathology.

[10]  Jag Bhawan,et al.  Incidental Microscopic Foci of Nevic Aggregates in Skin , 2008, The American Journal of dermatopathology.

[11]  S. Krengel Nevogenesis--new thoughts regarding a classical problem. , 2005, The American Journal of dermatopathology.

[12]  P. Carli,et al.  Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. , 2003, Journal of the American Academy of Dermatology.

[13]  J. Resneck,et al.  Ducking stray "magic bullets": a Melan-A alert. , 2003, The American Journal of dermatopathology.

[14]  V. Prieto,et al.  Atypical cells in human cutaneous re‐excision scars for melanoma express p75NGFR, C56/N‐CAM and GAP‐43: evidence of early Schwann cell differentiation , 2002, Journal of cutaneous pathology.

[15]  M. Kawashima,et al.  Dormant melanocytes in the dermis: do dermal melanocytes of acquired dermal melanocytosis exist from birth? , 1998, The British journal of dermatology.

[16]  C. Cockerell,et al.  Eruptive melanocytic nevi after Stevens-Johnson syndrome. , 1997, Journal of the American Academy of Dermatology.

[17]  R. Halaban,et al.  Proliferation and malignant transformation of melanocytes. , 1991, Critical reviews in oncogenesis.